ct-202
·Code: BA3362
ct-202: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Context Therapeutics Inc. (CNTX) | Phase 1 |
Get deeper analysis on ct-202
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis